🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s AQST Holdings & Trades

First Buy
Q3 2018
Duration Held
3 Quarters
Largest Add
Q1 2026
+283,734 Shares
Current Position
283,734 Shares
$1.18 M Value

Steven Cohen's AQST Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 283,734 shares of Aquestive Therapeutics, Inc. (AQST) worth $1.18 M, representing 0.00% of the portfolio. First purchased in 2018-Q3, this short-term holding has been held for 3 quarters.

Based on 13F filings, Steven Cohen has maintained this position in AQST for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 283,734 shares. Largest reduction occurred in Q4 2018, reducing 20,000 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Aquestive Therapeutics (AQST) Holding Value Over Time

Track share changes against reported price movement

Quarterly Aquestive Therapeutics (AQST) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +283,734 New Buy 283,734 $4.15
Q4 2018 -20,000 Sold Out 0 $0.00
Q3 2018 +20,000 New Buy 20,000 $17.50

Steven Cohen's Aquestive Therapeutics Investment FAQs

Steven Cohen first purchased Aquestive Therapeutics, Inc. (AQST) in Q3 2018, acquiring 20,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Aquestive Therapeutics, Inc. (AQST) for 3 quarters since Q3 2018.

Steven Cohen's largest addition to Aquestive Therapeutics, Inc. (AQST) was in Q1 2026, adding 283,734 shares worth $1.18 M.

According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 283,734 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $1.18 M.

As of the Q1 2026 filing, Aquestive Therapeutics, Inc. (AQST) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Aquestive Therapeutics, Inc. (AQST) was 283,734 shares, as reported at the end of Q1 2026.